Kurtz, Caroline B.

Development of a synthetic live bacterial therapeutic for the human metabolic disease phenylketonuria

Isabella, V. M., Ha, B. N., Castillo, M. J., Lubkowicz, D. J., Rowe, S. E., Millet, Y. A., Anderson, C. L., Li, N., Fisher, A. B., West, K. A., et al. (2018) · Nature Biotechnology

Bacterial Cancer TherapyProbiotics and Fermented Foods

Cited by 605

Developing a new class of engineered live bacterial therapeutics to treat human diseases

Charbonneau, M. R., Isabella, V. M., Li, N., & Kurtz, C. B. (2020) · Nature Communications

Bacterial Cancer TherapyProbiotics and Fermented Foods

Cited by 523

An engineered E. coli Nissle improves hyperammonemia and survival in mice and shows dose-dependent exposure in healthy humans

Kurtz, C. B., Millet, Y. A., Puurunen, M. K., Perreault, M., Charbonneau, M. R., Isabella, V. M., Kotula, J. W., Antipov, E., Dagon, Y., Denney, W. S., et al. (2019) · Science Translational Medicine

Bacterial Cancer TherapyAmino Acid Enzymes and Metabolism

Cited by 399

The effect of psyllium husk on intestinal microbiota in constipated patients and healthy controls

Jalanka, J., Major, G., Murray, K., Singh, G., Nowak, A., Kurtz, C., Silos-Santiago, I., Johnston, J. M., de Vos, W. M., & Spiller, R. (2019) · International Journal of Molecular Sciences

Gut microbiota and healthGastrointestinal motility and disorders

Cited by 219

Translational Development of Microbiome‐Based Therapeutics: Kinetics of E. coli Nissle and Engineered Strains in Humans and Nonhuman Primates

Kurtz, C., Denney, W. S., Blankstein, L., Guilmain, S. E., Machinani, S., Kotula, J., Saha, S., Miller, P., & Brennan, A. M. (2018) · Clinical and Translational Science

Probiotics and Fermented FoodsBacterial Cancer Therapy

Cited by 43